Northern Trust Corp Ocular Therapeutix, Inc Transaction History

Northern Trust Corp

  • $690 Billion
  • Q4 2024

A detailed history of Northern Trust Corp transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Northern Trust Corp holds 1,314,871 shares of OCUL stock, worth $9.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,314,871
Previous 1,246,697 5.47%
Holding current value
$9.57 Million
Previous $10.8 Million 3.52%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$8.33 - $11.47 $567,889 - $781,955
68,174 Added 5.47%
1,314,871 $11.2 Million
Q3 2024

Nov 13, 2024
BUY
$6.45 - $9.23 $1.08 Million - $1.55 Million
167,420 Added 15.51%
1,246,697 $10.8 Million
Q2 2024

Aug 14, 2024
BUY
$4.2 - $8.69 $458,551 - $948,765
109,179 Added 11.25%
1,079,277 $7.38 Million
Q1 2024

May 14, 2024
BUY
$3.85 - $10.93 $1.15 Million - $3.26 Million
298,114 Added 44.36%
970,098 $8.83 Million
Q4 2023

Feb 13, 2024
SELL
$2.08 - $4.52 $3,644 - $7,919
-1,752 Reduced 0.26%
671,984 $3 Million
Q3 2023

Nov 13, 2023
BUY
$3.14 - $5.04 $35,249 - $56,579
11,226 Added 1.69%
673,736 $2.12 Million
Q2 2023

Aug 11, 2023
BUY
$4.6 - $7.64 $24,899 - $41,355
5,413 Added 0.82%
662,510 $3.42 Million
Q1 2023

May 15, 2023
BUY
$2.79 - $6.27 $4,020 - $9,035
1,441 Added 0.22%
657,097 $3.46 Million
Q4 2022

Feb 13, 2023
BUY
$2.61 - $4.41 $7,253 - $12,255
2,779 Added 0.43%
655,656 $1.84 Million
Q3 2022

Nov 14, 2022
SELL
$4.09 - $6.5 $60,139 - $95,576
-14,704 Reduced 2.2%
652,877 $2.71 Million
Q2 2022

Aug 12, 2022
SELL
$3.01 - $5.22 $185,352 - $321,442
-61,579 Reduced 8.45%
667,581 $2.68 Million
Q1 2022

May 13, 2022
SELL
$4.83 - $7.35 $172,996 - $263,254
-35,817 Reduced 4.68%
729,160 $3.61 Million
Q4 2021

Feb 08, 2022
BUY
$6.16 - $12.07 $119,978 - $235,087
19,477 Added 2.61%
764,977 $5.33 Million
Q3 2021

Nov 15, 2021
SELL
$9.7 - $14.34 $427,973 - $632,695
-44,121 Reduced 5.59%
745,500 $7.46 Million
Q2 2021

Aug 13, 2021
BUY
$13.43 - $19.16 $9,092 - $12,971
677 Added 0.09%
789,621 $11.2 Million
Q1 2021

May 12, 2021
BUY
$15.82 - $22.11 $116,656 - $163,039
7,374 Added 0.94%
788,944 $12.9 Million
Q4 2020

Feb 11, 2021
BUY
$7.91 - $22.95 $787,685 - $2.29 Million
99,581 Added 14.6%
781,570 $16.2 Million
Q3 2020

Nov 16, 2020
BUY
$7.36 - $9.87 $272,570 - $365,525
37,034 Added 5.74%
681,989 $5.19 Million
Q2 2020

Aug 14, 2020
BUY
$4.67 - $8.95 $601,748 - $1.15 Million
128,854 Added 24.97%
644,955 $5.37 Million
Q1 2020

May 14, 2020
BUY
$3.95 - $7.4 $152,936 - $286,513
38,718 Added 8.11%
516,101 $2.56 Million
Q4 2019

Feb 14, 2020
SELL
$2.57 - $4.73 $25,802 - $47,489
-10,040 Reduced 2.06%
477,383 $1.89 Million
Q3 2019

Nov 13, 2019
BUY
$3.04 - $5.32 $205,020 - $358,786
67,441 Added 16.06%
487,423 $1.48 Million
Q2 2019

Aug 13, 2019
BUY
$2.46 - $4.52 $32,592 - $59,885
13,249 Added 3.26%
419,982 $1.85 Million
Q1 2019

May 13, 2019
BUY
$3.51 - $4.77 $11,551 - $15,698
3,291 Added 0.82%
406,733 $1.62 Million
Q4 2018

Feb 12, 2019
BUY
$3.87 - $7.11 $56,087 - $103,045
14,493 Added 3.73%
403,442 $1.61 Million
Q3 2018

Nov 14, 2018
BUY
$5.42 - $6.99 $142,665 - $183,990
26,322 Added 7.26%
388,949 $2.68 Million
Q2 2018

Aug 14, 2018
BUY
$5.99 - $8.17 $228,224 - $311,285
38,101 Added 11.74%
362,627 $2.45 Million
Q1 2018

May 09, 2018
BUY
$4.66 - $7.08 $293,547 - $445,990
62,993 Added 24.09%
324,526 $2.11 Million
Q4 2017

Feb 14, 2018
SELL
$3.73 - $6.37 $3,237 - $5,529
-868 Reduced 0.33%
261,533 $1.16 Million
Q3 2017

Nov 13, 2017
BUY
$5.28 - $6.88 $1.39 Million - $1.81 Million
262,401
262,401 $1.62 Million

Others Institutions Holding OCUL

# of Institutions
186
Shares Held
136M
Call Options Held
284K
Put Options Held
156K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $560M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email